Articles

With BluePeak? - blue laser autofluorescence you can noninvasively view the health of the RPE, providing a functional map of RPEphotoreceptor metabolism. BluePeak is available for all SPECTRALIS models.

Haag-Streit and our sister companies – Reliance, Moeller–Wedel, Clement Clarke and John Weiss – are leading players in ophthalmology today – as they have been for more than 150 years.

For nearly two centuries, Moria has been a manufacturer of sophisticated and high quality ophthalmic surgical instrumentation and equipment.

Micro incision surgery for anterior and posterior procedures is featured at the Oertli® booth.

Since introducing the first Laser photocoagulator to ophthalmology in 1970, Lumenis Vision has focused on providing ophthalmologists with innovative laser therapies to preserve and improve the sight of patients worldwide.

According to its press release GBI Research has found that the global ophthalmology market will grow at a moderate rate due to the impact of generic erosion in some markets such as glaucoma and allergic conjunctivitis.

For almost 60 years, the Geuder Group has been developing, manufacturing and distributing ophthalmo-surgical instruments, systems and vitreoretinal liquids.

STAAR Surgical has received CE mark approval for product improvements to its Visian Implantable Collamer Lens (ICL). It also received approval for a Hyperopic Toric ICL which is designed for patients with both hyperopia, as well as astigmatism.

An intact tear film and a good oxygen supply for the cornea are indispensable for contact lens wearing comfort. With the Keratograph TF-Scan software you can analyze the tear film non-invasively.

Experience the revolution in cross linking at booth 15 B 50 where bon Optic will be showing the new Ricrolin TE from the company Sooft.

The Ophthalmology TImes Europe team is looking forward to meeting many readers and customers at the Congress and to bringing you coverage of the event and new developments emerging from it.

Santen is a Japanese R&D focused pharmaceutical company specializing in the development and manufacturing of ophthalmic products.

Recent research by the Optical Express Group says it has revealed that of 32,000 clients surveyed following treatment in 2009, 89 per cent achieved 20/16 vision or better.

According to Novartis the independent DRCR.net study data being presented for the first time in the UK, show that ranibizumab is significantly more effective than laser treatment, the current standard of care, at treating visual impairment due to diabetic macular oedema (DMO).

A small German study of light adjustable lenses (LALs) implanted in 10 eyes in 7 patients has produced positive results, according to the lens's manufacturer, Calhoun Vision.

In a recent press statement Allergan Ltd announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended granting a Marketing Authorisation for OZURDEX (dexamethasone drug delivery system [DEX-DDS]) in the 27 member states of the European Union.

A new type of procedure for correcting short-sightedness could be safer than laser eye surgery, according to a new Cochrane Systematic Review. The study also shows that patients prefer the new procedure, despite there being little difference between the two in terms of improving vision.

Lux Biosciences, Inc. has announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application (NDA) for Luveniq (oral voclosporin) for the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye on June 28, 2010.

Team members of The Surgeless Sultans, The Diffractive Devils, The Chopping Conquerors and The Bursting Buccaneers will be given four minutes to talk about their most challenging cataract/complication cataract case ? with a little help from a video?

People with diabetes have an increased risk of blindness, yet nearly half of the approximately 23 million Americans with diabetes do not get an annual eye exam to detect possible problems. But it appears that cost-effective computerized systems to detect early eye problems related to diabetes can help meet the screening need, University of Iowa analysis shows.

Online research in the Archives of Opthalmology has reported that contact lenses for infants who had undergone surgery for unilateral congenital cataracts resulted in similar visual outcomes for those who received an IOL implant.

The first femtosecond-only method of laser vision correction from Carl Zeiss Meditec is now available for sale outside the United States.

The UK's National Health Service (NHS) is reported to be looking at the use of Avastin in lieu of Lucentis.

Posterior lamellar keratoplasty with DSAEK is a new surgical technique for the treatment of endothelial corneal diseases.

TearScience, has completed a $44.5 million of Series C funding from new investors.

Optos's scanning laser ophthalmoscope devices, the P200, P200C and P200MA have been used in a number of clinical studies, aimed at evaluating the effectiveness of an optomap ultra-widefield retinal scan in detecting potentially harmful lesions in the retina.

Highlighting the many developments from the burgeoning field of oculogenetics, Dr Edwin M. Stone, PhD, focuses on a successful gene therapy experiment, the increasing availability of clinical trials, and new technology that enhances genetic testing.

An approach to pre-treating two corneal conditions that makes for better refractive surgery by Asim Piracha, MD, Louisville, Kentucky, has been published in the Review of Ophthalmology.

The World Congress on Controversies In Ophthalmology (COPHy) will take place in Barcelona, Spain, from 3?6 March 2011, following the first event held in the Czech Republic in March this year.

The new AlphaSphere Orbital Implant ophthalmic device has been awarded the 2010 Alpha Award for Innovation In Engineering & Technology presented by the Engineering Society of Detroit.